Archive for the ‘Lyme’ Category

mRNA “Vaccines” Causing Microscopic Blood Clots – Why Lyme/MSIDS Patients Should Be Concerned

ALERT: Doctor says mRNA vaccines “will kill most people” through heart failure, 62% of vaccinated people already show microscopic blood clots

07/13/2021 / By Ethan Huff
ALERT: Doctor says mRNA vaccines “will kill most people” through heart failure, 62% of vaccinated people already show microscopic blood clots

The vast majority of people who are getting injected for the Wuhan coronavirus (Covid-19) will die within a few short years from heart failure, warns Dr. Charles Hoffe, M.D., a medical practitioner in British Columbia, Canada.

In one of his latest updates, Dr. Hoffe explains that he is observing in his patients who took an mRNA (messenger RNA) “vaccine” from either Pfizer-BioNTech or Moderna that their capillaries are now plugging up, which he says will eventually lead to a serious cardiovascular event.

Chinese Virus mRNA shots are programmed to turn a person’s body into a spike protein “factory,” and Dr. Hoffe says that over time these mass-produced spike proteins cause progressive blood clotting.

No fewer than 60 percent of people who take an mRNA injection will suffer from these blood clots – and in the end, an overwhelming majority will end up six feet under due to the damage caused.

“We now know that only 25 percent of the ‘vaccine’ injected into a person’s arm actually stays in your arm,” Dr. Hoffe explains one his blog.

“The other 75 percent is collected by your lymphatic system and literally fed into your circulation so these little packages of messenger RNA, and by the way in a single dose of Moderna ‘vaccine’ there are literally 40 trillion mRNA molecules.”

(See link for article & video of Dr. Hoffe)
________________________
**UPDATE**
For a very educational video on what the mRNA injections do inside the body:  https://www.brighteon.com/b246c5de-7b94-469d-b1ce-8f4acecd2152  Dr. Hoffe explains how the blood clots form after the shots.
This panel of doctors also explain the mechanism of COVID injection injury.  The spike protein circulates throughout the entire body.

**Comment**

After having patients complain of breathlessness and other concerning symptoms, Dr. Hoffe has been performing D-dimer tests on these “vaccinated” patients, which led him to discover that at least 62 percent of them have microscopic blood clots.

The idea of altered blood cells due to COVID isn’t new, a fact this website posted on back in May 2020 due to the seminal work of Italian pathologists utilizing 50 autopsies showing micro throbs, in the heart, brain, and kidneys, meaning the patients did not die of interstitial pneumonia as told initially, they died from a blood condition called disseminated intravascular coagulation (DIC) also found in the x-rays of the lungs.

It is only logical that the injections used for COVID would also alter blood vessels, and this is being seen on a daily basis.

In June, a study came out showing hyperinflammatory responses and coagulation disorders leading to congestions of microvessels to be key drivers. The authors found significant changes in lymphocyte stiffness, monocyte size, neutrophil size and deformability, and heterogeneity of erythrocyte deformation and size. Although some of these changes recovered to normal values after hospitalization, others persisted for months after hospital discharge, evidencing the long-term imprint of COVID-19 on the body.

The good news of course is there are cheap, effective treatments for COVID.  Unfortunately, these treatments are being highly censored.

Please notice the word microscopic blood clots. This means it will not be picked up unless looked for specifically utilizing specific tools. This is also where you should question to word rare, in that ‘authorities’ are stating it’s a rare occurrence.  There are numerous reasons for an effect to go unnoticed.  One reason would be they are utilizing the wrong tools when looking for it, and the other is doctors, let alone patients, don’t even know about the VAERS reporting system (click on link to see the plethora of blood clotting cases)  – as only 1% of vaccine injuries are reported.

The reason this should be especially concerning to Lyme/MSIDS patients is because a Russian study shows Lyme can also cause blood clots. Coinfections can as well, as risk factors for splanchnic vein thrombosis include infections.

Interestingly, heparin, a blood thinner, helps many MSIDS patients:  http://aac.asm.org/content/48/1/236.full.pdf Similarly with Bartonella, some respond miraculously to Heparin, which is a blood thinner. In the above link, heparin was found to inhibit Babesia growth. Horowitz also found it helps clear the parasites from the body.

Heparin helped my husband immensely.  His blood looked like snot and continually clotted in catheters.  He immediately felt improvement (energy, clearer mind) when heparin was added to his treatment protocol.

Hopefully it’s clear that infected Lyme/MSIDS patients are already in a high risk category due to infections.  Getting an experimental, fast-tracked injection known to cause blood clots on top of this risk is dangerous.

Important quote: 

“The most alarming part of this is that there are some parts of the body like the brain, spinal cord, heart and lungs which cannot [regenerate],” he says. “When those tissues are damaged by blood clots, they are permanently damaged.”  Dr. Hoffe

I just posted a perfect example of that here.  A man went into the ER with a severe headache after the COVID shot.  While there, he was diagnosed with Lyme Disease.

DOCTORS BELIEVE SPAULDING’S IMMUNE SYSTEM, WHICH WAS FIGHTING LYME DISEASE, WAS OVERSTIMULATED BY THE COVID VACCINE CAUSING IT TO ATTACK THE MYELIN — THE PROTECTIVE INSULATION THAT SURROUNDS NERVES, INCLUDING THOSE IN THE BRAIN AND SPINAL CORD.

Treatment was immediate and successful in arresting the progression of the disease, but not before Spaulding was almost completely paralyzed.

Almost completely paralyzed.

The insanity of what’s occurring in the world can not be overstated.  Workers are now going door to door trying to get people to receive these injections. Further, our current regime is planning to work with SMS carriers to dispel misinformation about vaccines that is sent over social media and text messages. In other words, censor your private communications.

This should trouble you.

These door to door workers have no medical training, do not know your medical history, but are trying to force you to make a major medical decision on the spot.  Don’t fall for it.  Don’t give them information, just ask them to leave. Do not allow bullies to affect your personal medical decision.

Your decision to receive medical treatment, including injections, is between you and your health care professional.  Shame on our government.  They are an embarrassment.

Go here for a great read written by a Constitutional attorney on the topic of door to door COVID strike-force teams.

Category:

Activism, Lyme, vaccines, Viruses

FDA Accepts Investigational Drug for Lyme Prevention

https://www.globenewswire.com/en/news-release/2021/05/04/2222816/0/en/Tarsus-Pharmaceuticals-Inc-Announces-FDA-Acceptance-of-Investigational-New-Drug-Application-for-TP-05-for-Lyme-Disease-Prevention

Tarsus Pharmaceuticals, Inc. Announces FDA Acceptance of Investigational New Drug Application for TP-05 for Lyme Disease Prevention

 | Source: Tarsus Pharmaceuticals, Inc

Novel candidate in development aims to be first approved non-vaccine therapeutic for Lyme disease prevention

Allows initiation of Phase 1 study to evaluate safety, pharmacokinetics, and dosing

More than 30 million Americans at risk for Lyme disease exposure, which can result in severe neurological and other debilitating symptoms

IRVINE, Calif., May 04, 2021 (GLOBE NEWSWIRE) — Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a late clinical-stage biopharmaceutical company whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients, starting with eye care, today announced that the U.S. Food and Drug Administration (FDA) has accepted the Company’s Investigational New Drug (IND) application for TP-05, an oral, non-vaccine therapeutic for the prevention of Lyme disease. With this IND acceptance, Tarsus will initiate a Phase 1 single ascending dose and multiple ascending dose (SAD/MAD) study to evaluate the safety, tolerability, and pharmacokinetics (PK) of TP-05 in healthy volunteers. Study initiation is anticipated in July.

“We are pleased that the FDA has accepted the IND for TP-05, which is an important milestone in our pipeline development. Currently, there are no approved pharmacological prophylactic options for tick kill and preventing transmission of Lyme disease, which has the potential to cause severe, often debilitating symptoms with permanent and irreversible damage,” said Bobak Azamian, M.D., Ph.D., President and Chief Executive Officer of Tarsus. “There is a significant unmet need for a therapeutic to quickly and reliably prevent this disease that can lead to poor outcomes for so many people. We look forward to initiating our clinical development program for TP-05 and advancing the path for this much-needed therapeutic for Lyme disease prevention.”

Lyme disease is transmitted to humans after the bite of a blacklegged tick infected with the Borrelia bacteria. It is the most common vector-borne disease in the United States and can result in inflammation, nerve, joint and muscle pain and swelling, numbness, shortness of breath and – in severe cases – neurological complications such as facial palsy, vision issues, and meningitis symptoms, including severe headaches and neck stiffness. Lyme disease impacts more than 300,000 people in the U.S. each year and over 30 million are at high or moderate risk for contracting the disease.

TP-05 is an oral systemic formulation of lotilaner, a well-characterized anti-parasitic agent that paralyzes and kills ticks by blocking the parasite-specific GABA-CI channels. TP-05 is believed to be the only non-vaccine based therapeutic in development and is designed to rapidly provide systemic blood levels of lotilaner, and kill infected ticks attached to the human body before they can transmit the Borrelia bacteria that causes Lyme disease. In addition to the prevention of Lyme disease, Tarsus is also exploring TP-05 for the community prevention of malaria.

Tarsus is currently conducting a pivotal trial evaluating the efficacy and safety of TP-03, a topical ophthalmic formulation of lotilaner, for the treatment of Demodex blepharitis, a common ocular condition caused by an infestation of Demodex mites.

About TP-05
TP-05 is an oral systemic formulation of lotilaner, a well-characterized anti-parasitic agent that paralyzes and kills parasites by inhibiting parasite-specific GABA-Cl channels. Tarsus is studying TP-05 for the prevention of Lyme disease. In July of 2021, Tarsus will initiate a Phase 1 single ascending dose and multiple ascending dose (SAD/MAD) study to evaluate the safety, tolerability and pharmacokinetics (PK) of TP-05 in healthy volunteers. In addition to Lyme disease, Tarsus is also exploring TP-05 for the community prevention of malaria.

About Lyme Disease
Lyme disease is the most common vector-borne disease in the United States, transmitted to humans after the bite of a blacklegged tick infected by the bacterium Borrelia burgdorferi. Over 30 million Americans are at high or moderate risk of contracting Lyme disease and there are approximately 300,000 – 400,000 cases in the U.S. each year. People who spend extended amounts of time outdoors in wooded, grassy areas are at higher risk of getting the infection. Data from the Centers for Disease Control (CDC) shows that the risk of Lyme disease is spreading to new geographical areas, resulting in a significant need for prophylactic solutions. Currently, there are no FDA-approved pharmacological prophylactic options for Lyme disease.

About Tarsus Pharmaceuticals, Inc.
Tarsus Pharmaceuticals, Inc. is a late clinical-stage biopharmaceutical company that applies proven science and new technology to revolutionize treatment for patients, starting with eye care. It is advancing its pipeline to address several diseases with high unmet need across a range of therapeutic categories, including eye care, dermatology, and infectious disease prevention. Its lead product candidate, TP-03, is a novel therapeutic in a pivotal Phase 2b/3 trial for the treatment of Demodex blepharitis. TP-03 is also being developed for the treatment of Meibomian Gland Disease.

Media Contact:
SuJin Oh
Shop PR
(917) 841-5213
sujin@shop-pr.com

Investor Contact:
Patti Bank
Westwicke Partners, an ICR company
(415) 513-1284
IR@tarsusrx.com

___________________

For more on Lotilaner:

  • https://parasitesandvectors.biomedcentral.com/articles/10.1186/s13071-017-2471-3
  • https://vetmed.illinois.edu/pet_column/fda-alert-on-flea-medications/  Only medications in the isoxazoline class of flea and tick medications are under investigation at this time. This includes Bravecto, Nexgard, Credelio, and Simparica (brand names for fluralaner, afoxolaner, lotilaner, and sarolaner).
  • Credelio contains the ingredient, lotilaner, which is an antiparasitic drug that kills the fleas and ticks that live on your pet’s body surface. Lotilaner blocks the transfer of chloride ions from passing through cell membranes, which causes uncontrolled neuromuscular activity and results in the death of fleas and ticks. Credelio starts killing fleas within 4 hours of administration and kills over 99% of fleas within 8 hours of administration. Credelio starts killing ticks* in 4 hours and 98.7% killed within 8 hours. *(Ixodes ricinus)  Source
  • https://ivcjournal.com/isoxazoline-flea-and-tick/  On September 20, 2018, the U.S. Food and Drug Administration (FDA) warned animal caregivers and veterinarians about the risk of serious neurologic events, including seizures, muscle tremors and ataxia, in dogs and cats treated with certain flea and tick medications. The warning applies to medications in the isoxazoline class — specifically, NexGard (afoxalaner), Bravecto (fluralaner), Simparica (sarolaner) and Credelio (lotilaner). The FDA updated their release on April 22, 2019 to include another recently-approved product in the isoxazoline class — namely, Revolution Plus (selamectin and sarolaner topical solution). The isoxazoline class encompasses a group of azolyl phenyl chemical compounds originally developed as parasiticides about 20 years ago. They are now widely used around the world. Adverse reactions to these compounds appear to affect animals randomly, although those with certain chronic diseases, the young and elderly, and animals that are immune-compromised or have the genetic mutation of the MDR1 gene are at higher risk.

Category:

Lyme, Prevention, Treatment

Patient With Facial Palsy From Lyme Disease Fails Treatment

https://danielcameronmd.com/patient-facial-palsy-from-lyme-disease-fails-treatment/

PATIENT WITH FACIAL PALSY FROM LYME DISEASE FAILS TREATMENT

facial palsy from lyme disease in elderly man

Facial palsy, sometimes referred to as Bell’s palsy, is considered an early sign of Lyme disease. When the infection is diagnosed in the early stage it is typically easier to treat. However, this case report features an elderly patient with facial palsy from Lyme disease who remained ill following treatment.

By 

In this case report, Hareem and colleagues describe a 71-year-old man with facial palsy from Lyme disease who failed treatment. The authors offer an inside look at what led up to the failed treatment.¹

Steroids associated with treatment failure?

The man was initially treated in August 2017 for an upper respiratory tract infection and prescribed the steroid dexamethasone. The previous year, he had a tick bite but no rash. One week later he was seen for a sore throat, right-sided ear pain, headache, dizziness, nausea, neck pain, and tinnitus. He had slight asymmetry of his smile.

Lyme disease Western blot test results were positive and the patient was prescribed doxycycline. However, several days later, the man returned with a complete facial palsy from Lyme disease. His condition had worsened.

“On his next visit, he complained of continuing right-sided headache and neck pain along with right-sided hearing loss, right-sided otalgia, dizziness, and nausea,” wrote the authors. His treatment was changed to cefuroxime.

Gait problems, hearing loss

Two weeks later his condition was even worse. “He continued to complain of gait instability and otalgia with hearing loss and neck pain,” wrote the authors. His treatment was changed to 30 days of doxycycline. He had an 80% hearing loss in the right ear and 25% in the left ear on audiology testing.

Authors’ conclusion

The man was diagnosed with “chronic Lyme disease from failed antibiotic therapy with simultaneous unilateral involvement of the seventh and eighth cranial nerves.”  He was prescribed an additional 4 weeks of doxycycline but remained ill. 

Wormer and colleagues previously discussed treatment failures in Lyme disease patients treated with steroids.2

Editor’s Note:  The 71-year-man never received a course of intravenous ceftriaxone. The authors did not discuss other diagnostic or treatment options.

Related Articles:

Steroids harmful to patients with Bell’s palsy caused by Lyme disease

Bell’s palsy can lead to non-flaccid facial palsy

Treatment varies for Bell’s palsy in children with Lyme disease

References:
  1. Hareem A, Dabiri I, Zaheer N, Burakgazi AZ. Medically Refractory Neuroborreliosis Case Presented with Coexistance Involvements of Cranial 7 and 8 Nerves. Neurol Int. Mar 18 2021;13(1):125-129. doi:10.3390/neurolint13010012
  2. Wormser GP, Brady KC, Cho MS, Scavarda CA, McKenna D. Efficacy of a 14-day course of amoxicillin for patients with erythema migrans. Diagn Microbiol Infect Dis. Jun 2019;94(2):192-194. doi:10.1016/j.diagmicrobio.2019.01.003

____________________

For more:

Category:

Lyme, research

A Comprehensive & Practical Review of Mold Toxicity & Its Complications

https://www.betterhealthguy.com/nathancrista2021

A Comprehensive & Practical Review of Mold Toxicity and its Complications

 Last Updated: May 05 2021
By Scott, The Better Health Guy

I had the opportunity to attend “A Comprehensive & Practical Review of Mold Toxicity and its Complications” held online on April 24-25, 2021.  This event was a wonderful collaboration between Neil Nathan, MD and Jill Crista, ND.

Disclaimer: Nothing in this text is intended to serve as medical advice. All medical decisions should be made only with the guidance of your own personal licensed medical authority.

Disclaimer: This information was taken as notes during the training course and may not represent the exact statements of the speakers. Errors and/or omissions may be present.

Note: As this information may be updated as any errors are found, I kindly request that you link to this single source of information rather than copying the content below. If any updates or corrections are made, this will help to ensure that anyone reading this is getting the most current and accurate information available.

Go to top link for article and notes

____________________

For more:

Mold toxicity is a big deal and needs to be addressed before some Lyme/MSIDS patients experience improvement.  Again, Lyme literate doctors are educated in these issues.

Category:

Activism, Lyme, Mold, Treatment

Lyme Coinfection Comparisons: What Your Symptoms Could Be Telling You

https://rawlsmd.com/health-articles/lyme-coinfection-comparisons-what-your-symptoms-could-be-telling-you

lyme-coinfection-comparisons-what-symptoms-could-be-telling-you

Lyme Coinfection Comparisons Charts: What Your Symptoms Could Be Telling You

by Jenny Lelwica Buttaccio and Mark Casey
Posted 5/14/21

One of the most challenging aspects of reclaiming your health from chronic Lyme disease is knowing where to turn when new or different symptoms pop up. “My perception after studying a variety of intracellular microbes for years is that each microbe has a preference for different types of cells in the body,” says Dr. Bill Rawls, Medical Director of RawlsMD and Vital Plan.

For example, Borrelia burgdorferi, the predominant bacteria that causes Lyme disease in the United States, has an affinity for collagenous tissues in the body. Therefore, the symptoms that come with borrelia infection tend to impact those areas with high concentrations of collagen: the brain, joints, muscles, etc. But some additional, unexpected symptoms can arise from Lyme coinfections (simultaneous infections), and it’s not always easy to figure out which microbe is the chief, problem-causing culprit, especially since testing for Lyme disease and coinfections is woefully inaccurate.

Coinfections at a Glance

Though the symptoms of borrelia often get top billing when it comes to Lyme disease, there’s rarely a single microbe at play when you’re dealing with persistent symptoms. Besides Lyme, the main coinfections that patients often contend with include babesia, bartonella, and mycoplasma. Below is a brief description of each one:

  • Babesia: A distant cousin of malaria, babesia is a protozoan and parasite most commonly transmitted by blacklegged ticks.
  • Bartonella: Typically spread by biting insects (fleas, ticks, mosquitoes, sandflies, lice, chiggers, biting flies, scabies, mites, and louse-eating spiders), there are more than a dozen species of bartonella that can impact human health, giving rise to the broader-named category called bartonella-like organisms (BLO).
  • Mycoplasma: Mycoplasma is the smallest of all bacteria, and because it lacks a cell wall, it can alter its shape and travel to areas of the body where other microbes can’t go. It’s spread by biting insects (ticks, mosquitoes, fleas, biting flies), sexual contact, contaminated food, and airborne droplets. The majority of people will have exposure to some form of mycoplasma in their lifetime.

“The reason you’re having symptoms from Lyme and coinfections is that each of these microbes is affecting certain cells in the body, and it could be either one microbe or several microbes contributing to the problem,” says Dr. Rawls. “Every person’s symptoms are a little bit different because the spectrum of microbes they carry is different.”

Thus, understanding key characteristics of these more common Lyme disease coinfections can serve as a guide for you and your physician to best target your treatment. “Knowing if you have, say, bartonella or babesia can help you figure out if you need to add on additional herbal therapies or remedies to support your recovery efforts,” explains Dr. Rawls.

So to assist you, we’ve put together seven coinfection comparison graphics, highlighting the similarities, differences, and telltale signs between borrelia, babesia, bartonella, and mycoplasma, frequent infections that often go hand in hand.

Lyme Disease Coinfection Comparisons

The following two graphics demonstrate the telltale and shared signs and symptoms of borrelia, babesia, bartonella, and mycoplasma that you might not be aware of. Having information about which symptoms are distinct to a particular infection and which ones overlap with others can aid you in identifying the various pathogens you might be dealing with or may have overlooked in your current treatment regimen.

Telltale and Shared Signs and Symptoms

circle chart of telltale symptoms. Borrelia: stiff neck, lyme carditis, eye floaters, bulls eye rash, bells palsy, migrating arthritis, joint welling. Mycoplasma: respiratory infection, sinus problems. Babesia: chest or rib pain, drenching night sweats, body temperature fluctuations, air hunger. Bartonella: rage, swollen lymph nodes, unexplained cough, stretch-mark like rash, pain in shins, pain in soles of feet
overlapping circle chart os shared symptoms: depression, anxiety, headache, cognitive difficulties, brain fog, sleep problems, fatigue, fever, chills, autoimmunity, gastrointestinal function, bladder irritation, muscle pain, joint pain

Borrelia and Beyond

Here, we’ve detailed a more complete snapshot of the range of symptoms borrelia, babesia, bartonella, and mycoplasma infections can cause. Bear in mind that many symptoms are similar, so it’s crucial to evaluate your overall symptom profile to get a more accurate diagnosis of what might be going on with you.

The next four graphics allow you to see how Lyme and coinfections could be affecting different systems of the body and influencing how you feel:

Borrelia

symptoms of borrelia infection: depression, anxiety, headache, cognitive difficulties, brain fog, sleep problems, dizziness, visual changes, eye floaters, sound sensitivity, ringing in ears, bells palsy, stiff neck, heart symptoms, lyme cariditis, fatigue, fever, chills, autoimmunity, migrating arthritis, burning or tingling hands, tremors, gastrointestinal dysfunction, bladder irritation, bulls eye rash, muscle pain, joint pain, joint swelling, muscle twitching

Babesia

symptoms of babesia infection: depression, anxiety, headache, cognitive difficulties, brain fog, sleep problems, dizziness, heart symptoms, anemia, chest or rib pain, air hunger, fatigue, fever, chills, autoimmunity, drenching night sweats, body temperature fluctuations, gastrointestinal dysfunction, bladder irritation, petechiae, jaundice, dark urine, muscle pain, joint pain

Bartonella

symptoms of bartonella infection: depression, anxiety, rage, headache, cognitive difficulties, brain fog, sleep problems, eye infection and eye problems, tooth pain, swollen lymph nodes, heart symptoms, anemia, unexplained cough, fatigue, fever, chills, autoimmunity, gastrointestinal dysfunction, bladder irritation, stretchmark-like rash, muscle pain, joint pain, pain in shins, pain in soles of feet

Mycoplasma

symptoms of mycoplasma, depression, anxiety, headache, cognitive difficulties, brain fog, sleep problems, eye infection and eye problems, ringing in ears, sinus problems, heart symptoms, respiratory infection, fatigue, fever, chills, autoimmunity, burning or tingling hands, gastrointestinal dysfunction, bladder irritation, muscle pain, joint pain

The Takeaway

chart marking borrelia, babesia, bartonella, and mycoplasma for general, neurological, visual, lymphatic, cardiovascular, respiratory, immune, urogenital, gastrointestinal, musculoskeletal, or integumentary symptoms

Final Thoughts

When it comes to overcoming chronic Lyme disease, gauging what to treat can sometimes be confusing due to the widespread set of symptoms you may be experiencing. However, you can use these graphics to help distinguish between overlapping symptoms and those that are distinct to specific pathogens. Combine this information with a comprehensive natural protocol and work your way through potential coinfections to move toward better, more vibrant health again.

Dr. Rawls is a physician who overcame Lyme disease through natural herbal therapy. You can learn more about Lyme disease in Dr. Rawls’ new best selling book, Unlocking Lyme.

You can also learn about Dr. Rawls’ personal journey in overcoming Lyme disease and fibromyalgia in his popular blog post, My Chronic Lyme Journey.

______________________

For more:

Unfortunately, MSM still believes this is a one pathogen, one drug disease when nothing could be further from the truth.  Dealing with coinfections is a must and they are just as severe and dangerous as Lyme.  Treating this complex illness is like peeling back the layers of an onion.  Symptoms will wax and wane and new ones will crop up.  Understanding how to treat this requires a Lyme literate doctor.  Don’t mess around with MSM.  All it will do is take your money, abuse you, and cause you more suffering and pain.

To date, there are 19 and counting pathogens that could be transmitted by the singular bite of a tick.

Lyme is just the rock star we know by name. Also, it’s important to understand this complex illness does a number on the immune system. You are essentially a host and these pathogens deplete many important hormones, minerals, etc., requiring you to supplement and address these deficiencies.

To read of one man’s experience being infected with multiple pathogens go here.

Unfortunately, the article erroneously states this is rare. Everyone I work with is infected with at least 3 pathogens, and many have more than that. This makes cases more severe and harder to treat.

Category:

Babesia, Bartonella, Lyme, Mycoplasma, Uncategorized